Intermediate Capital Group PLC

Amundi has acquired a 9.9% economic interest in alternatives asset manager ICG in a deal worth about €620m, or $711.4m, following the long-term strategic and equity partnership the two firms agreed in November 2025. Under a 10-year arrangement tied to the deal, Amundi will serve as the sole global distributor in the wealth channel for ICG's evergreen products and certain other offerings, while ICG will be the exclusive supplier of those products to Amundi's distribution business. The agreement also covers the joint creation of new products aimed at wealth investors, with the first, centred on private equity secondaries, due to be introduced in the coming weeks. Amundi CEO Valérie Baudson said the partnership marks a significant step in the development of Amundi's private markets offering, and ICG CEO and chief investment officer Benoît Durteste said the deal is the first step in realising the commercial benefits of the collaboration.

ICG plc announced that between 1 September and 8 September 2026 it purchased 706,778 ordinary shares on the London Stock Exchange through Merrill Lynch International as part of its share buyback programme launched on 19 February 2026. The buyback supports the company's strategic partnership with Amundi, announced on 18 November 2025, by enabling ICG to issue an equal number of non-voting shares to Amundi without diluting existing shareholders. The shares were bought at prices ranging from 1902.00 to 1970.00 pence per share, with daily volume-weighted average prices between 1917.79 and 1958.29 pence. Following settlement, ICG will have 282,260,661 ordinary shares in issue, of which 6,824,448 are held in treasury, plus 13,465,175 non-voting shares, bringing total voting rights to 275,436,213. The repurchased shares will be held in treasury and cancelled in tranches at least bi-annually.

ICG plc purchased 633,510 ordinary shares between 27 July and 31 July 2026 as part of its share buyback programme announced on 19 February 2026. The purchases were executed on the London Stock Exchange through Merrill Lynch International, with daily volumes ranging from 122,872 to 129,621 shares at volume-weighted average prices between 1896.08 pence and 1922.28 pence. The buyback is intended to facilitate the non-dilutive issuance of Ordinary Non-Voting shares to Amundi under the strategic partnership announced on 18 November 2025. Following settlement, the company will have 282,260,661 ordinary shares in issue, with 4,486,448 held in treasury and 11,349,022 Ordinary Non-Voting shares outstanding, resulting in 277,774,213 total voting rights.

ICG plc repurchased 508,170 ordinary shares between 13 July and 17 July 2026 as part of its share buyback programme announced on 19 February 2026. The purchases were executed on the London Stock Exchange through Merrill Lynch International, with daily volumes ranging from 17,264 to 136,130 shares and volume-weighted average prices between 1779.88 pence and 1900.75 pence. The buyback is designed to enable the non-dilutive issuance of Ordinary Non-Voting shares to Amundi in connection with the strategic partnership announced on 18 November 2025. Acquired shares will be held in treasury and eventually cancelled in tranches at least bi-annually. Following settlement, the company will have 282,260,661 ordinary shares in issue, with 3,204,579 held in treasury and 9,058,864 Ordinary Non-Voting shares outstanding, resulting in total voting rights of 279,056,082.

Societe Generale has increased its total voting rights in ICG PLC to 9.510383% following an acquisition that crossed the notification threshold on 16 July 2026. The resulting position comprises 26,615,542 direct voting rights, representing 9.429420% of the issuer, and financial instruments with similar economic effect—specifically three contracts for difference—accounting for a further 0.080963%. The total number of voting rights held is 26,844,070, up from a previously notified 6.343524%. The notification was completed on 17 July 2026 in London.

ICG reported fee-earning assets under management of $88 billion for the three months ended 30 June 2026, a 3% increase from the prior quarter and a 10% rise year-on-year on a constant currency basis. Total AUM stood at $126 billion, with net additions to fee-earning AUM of $2.4 billion driven by $4.4 billion in gross additions and $2.0 billion in realisations. Fundraising reached $4.1 billion in the quarter, led by $2.2 billion for Structured Capital & Secondaries, including $2.1 billion for Europe IX, which stood at €11 billion and is on track to close at €12 billion, making it ICG’s largest-ever co-mingled fund and the largest structured capital fund ever raised globally. The company also announced the launch of SRE III and SDP VI, with first closes expected before the end of FY27, and declared a final dividend of 59.3p per share for FY26, payable on 31 July 2026.

ICG plc has purchased 272,588 ordinary shares on 22 and 23 June 2026 as part of its share buyback programme announced on 19 February 2026. The purchases were executed on the London Stock Exchange through Merrill Lynch International, with 134,484 shares bought on 22 June at a volume-weighted average price of 1,741.82 pence and 138,104 shares on 23 June at 1,741.55 pence. The buyback is designed to facilitate the issuance of an equal number of ordinary non-voting shares to Amundi in a non-dilutive manner, linked to the strategic partnership announced on 18 November 2025. The acquired shares will be held in treasury and eventually cancelled in tranches at least bi-annually. Following settlement, the company has 282,260,661 ordinary shares in issue, with 1,601,290 held in treasury and 9,058,864 ordinary non-voting shares, resulting in total voting rights of 280,659,371.